Suvoda Executive and Leadership Team

Jagath Wanninayake, the Chief Executive Officer at Suvoda, directs the overarching corporate strategy and long-term vision for the organization. By prioritizing the development of innovative Interactive Response Technology, the Chief Executive Officer ensures that clinical trials maintain high standards of patient safety and operational efficiency. Wanninayake oversees the alignment of global teams to support biopharmaceutical clients across diverse international markets. This leadership role involves constant evaluation of market trends to maintain a competitive edge in the SaaS health sector. Through rigorous focus on product scalability and customer success, the Chief Executive Officer drives the company toward sustainable growth. By fostering a culture of technical excellence, Jagath Wanninayake empowers the entire organization to solve complex supply chain challenges. Ultimately, the Chief Executive Officer secures the company position as a leader in clinical trial technology.

Brian Greenfield, the Chief Financial Officer at Suvoda, directs the financial planning, reporting, and capital allocation strategies for the organization. Overseeing the fiscal health of the company, the Chief Financial Officer ensures that investments in SaaS innovation and global expansion remain sustainable. Greenfield manages the financial risk associated with supporting complex clinical trials, providing the necessary stability for long-term growth. This leadership role involves close coordination with the Board to align financial performance with the strategic objectives of the business. By implementing robust financial controls, the Chief Financial Officer supports the scalability of the platform and the expansion of customer advisory services. Brian Greenfield directly impacts the ability of the company to deliver high-quality technology solutions to biopharmaceutical clients. Through disciplined fiscal management, the Chief Financial Officer secures the resources required for ongoing product development. Ultimately, Greenfield maintains the financial integrity of the organization.

Jp Samar, the Chief Financial Officer & Founder at Suvoda, drives the long-term financial architecture and foundational growth strategy of the company. Overseeing the capital structure, the Chief Financial Officer & Founder ensures that the organization maintains the resources necessary to innovate within the clinical trial technology space. Samar focuses on the strategic integration of financial planning with the core mission of solving complex patient randomization challenges. This leadership role involves evaluating new market opportunities and ensuring that the business model remains resilient against industry shifts. By leveraging deep institutional knowledge, the Chief Financial Officer & Founder guides the company through critical phases of expansion. Jp Samar directly impacts the strategic direction by balancing immediate operational needs with future-oriented investments. Through consistent oversight of financial performance, the Chief Financial Officer & Founder supports the delivery of advanced functionality to global clients. Ultimately, Samar ensures the enduring success of the business.

John Samar, the Chief Financial Officer & Founder at Suvoda, manages the strategic financial partnerships and long-term economic sustainability of the organization. Overseeing the alignment of financial assets with product development goals, the Chief Financial Officer & Founder ensures that the company remains at the forefront of clinical trial innovation. Samar focuses on optimizing the financial framework to support the global delivery of Interactive Response Technology. This leadership role involves identifying key investment areas that enhance the platform ability to handle complex study designs. By maintaining strong relationships with stakeholders, the Chief Financial Officer & Founder secures the necessary backing for continued technological advancement. John Samar directly impacts the operational scale of the company by ensuring efficient resource distribution across international offices. Through strategic financial oversight, the Chief Financial Officer & Founder supports the mission of providing peace of mind to clinical trial customers. Ultimately, Samar drives the financial stability of the firm.

Robert Hummel, the Chief Operating Officer at Suvoda, manages the daily operational infrastructure and service delivery models that support clinical trial success. Overseeing the implementation of Interactive Response Technology, the Chief Operating Officer ensures that client requirements for patient randomization and supply chain management receive precise technical execution. Hummel drives the optimization of internal processes to maintain high service standards for biopharmaceutical partners. This leadership role involves scaling operational capacity to meet the demands of complex, global study designs. By monitoring performance metrics, the Chief Operating Officer identifies opportunities for efficiency improvements across all service departments. Robert Hummel directly impacts the reliability of the platform by enforcing rigorous quality control standards. Through strategic resource allocation, the Chief Operating Officer supports the expansion of the company into new international territories. Ultimately, Hummel guarantees that the operational framework remains robust and scalable.

Yuko Fukasaku, the President, Suvoda (Japan) at Suvoda, directs all regional operations and market expansion efforts within the Japanese clinical trial sector. Overseeing the local implementation of Interactive Response Technology, the President, Suvoda (Japan) ensures that the platform meets the specific regulatory and operational requirements of the regional market. Fukasaku drives the growth of the local team, fostering strong relationships with biopharmaceutical companies and clinical research organizations. This leadership role involves adapting global strategies to fit the unique nuances of the local healthcare landscape. By providing exceptional advisory services, the President, Suvoda (Japan) enhances the reputation of the company as a trusted partner in clinical research. Yuko Fukasaku directly impacts the regional revenue by ensuring that the technology effectively solves complex patient randomization challenges for local clients. Through strategic market penetration, the President, Suvoda (Japan) strengthens the global footprint of the organization. Ultimately, Fukasaku ensures regional success.

Elena Filimonova, the Chief Marketing Officer at Suvoda, architects the global brand strategy and market positioning for the company. Overseeing all demand generation and communications, the Chief Marketing Officer ensures that the value proposition of the Interactive Response Technology reaches biopharmaceutical companies and clinical research organizations effectively. Filimonova drives initiatives that highlight the technical advantages of the platform, specifically focusing on how configurable features support complex study designs. This leadership role requires close collaboration with product teams to translate advanced functionality into clear market messaging. By analyzing industry data, the Chief Marketing Officer optimizes outreach strategies to expand the company footprint across North American and European markets. Elena Filimonova directly impacts the growth trajectory by building strong awareness of the platform capabilities. Ultimately, the Chief Marketing Officer strengthens the market presence of the organization through targeted, data-driven campaigns.

Kelly Snow, the Chief of Staff at Suvoda, coordinates cross-functional initiatives and streamlines internal operations to support the executive leadership team. Overseeing the execution of strategic priorities, the Chief of Staff ensures that organizational goals remain aligned with the mission of transforming clinical trials through technology. Snow facilitates communication between departments, enabling efficient decision-making processes that impact the entire company. This leadership role involves managing high-level projects that require deep integration of product development and customer service functions. By optimizing internal workflows, the Chief of Staff enhances the overall productivity of the organization. Kelly Snow directly supports the operational health of the company by removing bottlenecks and fostering collaboration across global offices. Through meticulous planning and oversight, the Chief of Staff maintains the focus of the leadership team on critical business outcomes. Ultimately, Snow ensures the seamless operation of the business.

Andrew Prangle, the Account Executive & Chief Revenue Officer, Partnerships at Suvoda, directs the revenue generation strategy through strategic alliances and key account management. Overseeing the expansion of the partner ecosystem, the Account Executive & Chief Revenue Officer, Partnerships ensures that the company effectively reaches biopharmaceutical organizations of all sizes. Prangle drives the development of collaborative relationships that integrate the Interactive Response Technology into broader clinical research workflows. This leadership role involves identifying new market segments and tailoring the value proposition to meet specific client needs. By managing high-value accounts, the Account Executive & Chief Revenue Officer, Partnerships directly impacts the top-line growth of the organization. Andrew Prangle facilitates the alignment of sales efforts with the technical capabilities of the platform to ensure customer satisfaction. Through proactive partnership development, the Account Executive & Chief Revenue Officer, Partnerships expands the global reach of the company. Ultimately, Prangle secures long-term revenue streams.